[go: up one dir, main page]

WO2001075054A3 - A novel polypeptide, microglobulin transcription human regulation factor 30 and the polynucleotide encoding the polypeptide - Google Patents

A novel polypeptide, microglobulin transcription human regulation factor 30 and the polynucleotide encoding the polypeptide Download PDF

Info

Publication number
WO2001075054A3
WO2001075054A3 PCT/CN2001/000504 CN0100504W WO0175054A3 WO 2001075054 A3 WO2001075054 A3 WO 2001075054A3 CN 0100504 W CN0100504 W CN 0100504W WO 0175054 A3 WO0175054 A3 WO 0175054A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptide
regulation factor
discloses
polynucleotide encoding
microglobulin transcription
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2001/000504
Other languages
French (fr)
Chinese (zh)
Other versions
WO2001075054A2 (en
Inventor
Yumin Mao
Yi Xie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Biowindow Gene Development Inc
Original Assignee
Shanghai Biowindow Gene Development Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Biowindow Gene Development Inc filed Critical Shanghai Biowindow Gene Development Inc
Priority to AU63729/01A priority Critical patent/AU6372901A/en
Publication of WO2001075054A2 publication Critical patent/WO2001075054A2/en
Publication of WO2001075054A3 publication Critical patent/WO2001075054A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention discloses a novel polypeptide, a microglobulin transcription human regulation factor 30, the polynucleaotide encoding the polypeptide and the method for producing the polypeptide by DNA recombinant technology. The invention also discloses the uses of the polypeptide in methods for treating various diseases, such as malignant tumor, hemopathy, development disorders, HIV infection, immunological disease, and various inflammation, etc. The invention also discloses the agonists against the polypeptide and the therapeutic action thereof. The invention also discloses the uses of the polynucleotide encoding the microglobulin transcription human regulation factor 30.
PCT/CN2001/000504 2000-03-29 2001-03-26 A novel polypeptide, microglobulin transcription human regulation factor 30 and the polynucleotide encoding the polypeptide Ceased WO2001075054A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU63729/01A AU6372901A (en) 2000-03-29 2001-03-26 A novel polypeptide, microglobulin transcription human regulation factor 30 and the polynucleotide encoding the polypeptide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN 00115284 CN1315448A (en) 2000-03-29 2000-03-29 Polypeptide-human microglobulin transcription regulating factor 30 and polynucleotide for coding it
CN00115284.X 2000-03-29

Publications (2)

Publication Number Publication Date
WO2001075054A2 WO2001075054A2 (en) 2001-10-11
WO2001075054A3 true WO2001075054A3 (en) 2002-04-18

Family

ID=4584752

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000504 Ceased WO2001075054A2 (en) 2000-03-29 2001-03-26 A novel polypeptide, microglobulin transcription human regulation factor 30 and the polynucleotide encoding the polypeptide

Country Status (3)

Country Link
CN (1) CN1315448A (en)
AU (1) AU6372901A (en)
WO (1) WO2001075054A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003048358A1 (en) 2001-12-07 2003-06-12 Nissui Pharmaceutical Co., Ltd. Adipocyte differentiation-associated gene and protein

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BRECHT S. ET AL., GENE, vol. 234, no. 2, 8 July 1999 (1999-07-08), pages 239 - 247 *
DATABASE GENBANK [online] 29 August 1998 (1998-08-29), WOESSNER J. ET AL., Database accession no. (AF086377) *
GUSSOW D. ET AL., J. IMMUNOL., vol. 139, no. 9, 1 November 1987 (1987-11-01), pages 3132 - 3138 *
LALLEMAND C. ET AL., J. BIOL. CHEM., vol. 272, no. 47, 21 November 1997 (1997-11-21), pages 29801 - 29809 *
TODA K. ET AL., EUR. J. BIOCHEM., vol. 231, no. 2, 15 July 1995 (1995-07-15), pages 292 - 299 *

Also Published As

Publication number Publication date
AU6372901A (en) 2001-10-15
CN1315448A (en) 2001-10-03
WO2001075054A2 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
WO2001083688A3 (en) A novel polypeptide, a human subunit 13 phosphatidylinositol-4-phosphate-5-kinase ii beta and the polynucleotide encoding the polypeptide
WO2001075054A3 (en) A novel polypeptide, microglobulin transcription human regulation factor 30 and the polynucleotide encoding the polypeptide
WO2002000822A3 (en) A NOVEL POLYPEPTIDE, A HUMAIN PROTEIN SYNTHESIS INITIATION FACTOR SUB-UNIT 2 β 16.5 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
WO2001075018A3 (en) A novel polypeptide, a human regulation factor of transcription 31 and the polynucleotide encoding the polypeptide
WO2001075036A3 (en) A novel polypeptide, human immunophiline 14 and the polynucleotide encoding the polypeptide
WO2001075062A3 (en) A novel polypeptide, human hydrogenase 10 and the polynucleotide encoding the polypeptide
WO2001075053A3 (en) A novel polypeptide, human chaperonine 14 and the polynucleotide encoding the polypeptide
WO2001094534A3 (en) A novel polypeptide, a human transcription factor 9.57 and the polynucleotide encoding the polypeptide
WO2001079439A3 (en) A novel polypeptide, a human cannabinoid receptor protein 19 and the polynucleotide encoding the polypeptide
WO2001075025A3 (en) A novel polypeptide, human thyroglobuline 9 and the polynuceotide encoding the polypeptide
WO2001075016A3 (en) A novel polypeptide, a human tyrosinase 16, and the polynucleotide encoding the polypeptide
WO2001075023A3 (en) A novel polypeptide, human phosphatidylinositol-3 (ptdins 3) kinase 9 and the polynucleotide encoding the polypeptide
WO2001081537A3 (en) A NOVEL POLYPEPTIDE, DNA REPLICATION FACTOR C(A1) 37Kd HUMAN SUB-UNIT 49, AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
WO2001075029A3 (en) A novel polypeptide, nf-e2-associated human factor 11 and the polynucleotide encoding the polypeptide
WO2001075011A3 (en) A novel polypeptide, cytochrome human constitution protein 10 and the polynucleotide encoding the polypeptide
WO2001075058A3 (en) A NOVEL POLYPEPTIDE, HUMAN AMINOACYL-tRNA SYNTHETASE 15 TYPE II AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
WO2001075024A3 (en) A novel polypeptide, nf-e2-associated human factor 13 and the polynucleotide encoding the polypeptide
WO2001079433A3 (en) A novel polypeptide, a human cell differentiation transcription factor 13 and the polynucleotide encoding the polypeptide
WO2001083685A3 (en) A novel polypeptide, a cap protein 10 and the polynucleotide encoding the polypeptide
WO2001083681A3 (en) A novel polypeptide, a human dihydroorotase 21 and the polynucleotide encoding the polypeptide
WO2001077287A3 (en) A novel polypeptide, human uterine globine 11 and the polynucleotide encoding the polypeptide
WO2001075056A3 (en) A novel polypeptide, human light-chain clathrine 20 and the polynucleotide encoding the polypeptide
WO2001075046A3 (en) A novel polypeptide, mitotic cycle human regulation gene 17 and the polynucleotide encoding the polypeptide
WO2001075060A3 (en) A novel polypeptide, human cystein protease 9 and the polynucleotide encoding the polypeptide
WO2001075014A3 (en) A novel polypeptide, human phosphatidylinositol-3 (ptdins 3) kinase 35 and the polynucleotide encoding the polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP